The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related ...

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

Even as new technologies transform healthcare, local leaders emphasized the importance of never losing the human touch within ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...

Investors know the biotech industry is a waiting game—smaller companies in this space often work to secure the funding to ...

Nazara Technologies reported 19.1% jump in consolidated net profit to Rs 30.68 crore in Q3 FY25 as compared with Rs 25.77 crore in Q3 FY24. Net sales increased 66.9% to Rs 534.69 crore during the ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

A look at the M&A and stock market pictures for full-year 2024—and the potential strategic implications for pharma and ...